Business Wire

Huawei Launch Track AI to Help Detect Early Signs of Visual Impairment in Children across the World

Share

Huawei has deployed its AI expertise with leading medical research bodies to help safeguard children's eyesight. Huawei is working with IIS Aragon and DIVE Medical to co-create Track AI, an AI-powered assessment designed to detect and diagnose early signs of visual impairment in children.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190415005748/en/

The World Health Organization estimates there are 19 million children in the world with visual impairment, of which 70 to 80 percent are preventable or curable. In most cases, these children will remain undiagnosed for years, resulting in more serious consequences with their vision, general development, educational and social opportunities. Less severe but easily prevented types of visual impairments are currently affecting 12.8 million children.

For the past few years, we have been committed to developing a tool that will assess visual function in young children and to identify those with visual impairments,” said Victoria Pueyo, Paediatric Ophthalmologist, DIVE Medical.

“With Huawei supporting and powering DIVE through AI we are now able to work towards this goal. Our goal is to implement this technology globally and with our multi-ethnic approach we can cater to every type of visual impairment.”

To detect visual impairments, the DIVE (Devices for an Integral Visual Examination) software runs on the Matebook E to monitor and track the gaze of each eye while the patient is looking at stimuli designed to test different aspects of visual function. The data collected from the patients’ gaze pattern is then processed on the HUAWEI P30 smartphone using the HUAWEI HiAI algorithm to identify potential indicators of visual impairments.

With the HUAWEI P30 and HUAWEI HiAI technology, the Track AI initiative creates an easy-to-use, portable and affordable device to identify these issues in children as soon as possible and as early as six months old. Ultimately, the goal is to empower individuals without training to help identify children that may have visual impairments in order to help them access treatment sooner.

In the past, smartphones were not powerful enough to process complex AI based algorithms and data had to be sent to the cloud for processing. Communication to and from the cloud makes AI processing slow and is useless without a network. The new Track AI technology combines the very best in Huawei’s machine learning and on-device AI processing technology with concrete research and insights from IIS Aragon and DIVE Medical, said Peter Gauden, Technology Expert, Huawei.

Track AI is part of Huawei’s wider commitment to push the boundaries of what is humanly possible and use AI for good. Our goal for this project is to make it possible for parents and doctors in all corners of the world to detect visual impairments in a faster, easier, more efficient way through AI technology.”

How does it work?

Children with visual impairment have different gaze patterns compared to children with normal vision. DIVE can accurately gather data on the gaze position during a scientifically designed visual stimuli. Interpreting this data can be challenging for non-specialist healthcare workers. Using AI, however, computers can be trained to identify abnormal gaze patterns for easier screenings and assisted diagnoses and speed up the process from diagnosis to management of the condition.

Track AI builds on the capabilities of Google’s TensorFlow, an open-source platform, and Huawei HiAi, to create a machine learning system on a smartphone using its breakthrough Kirin 980 chip, an AI processing powerhouse that is defining the future of smartphone AI.

Two dedicated Neural Processing Units (Dual NPU) built inside the Kirin 980 support on-device AI which means the AI functions are processed on the smartphone itself, significantly speeding things up while also preserving user privacy. This Dual Neural Processing Unit also helps to make the Smartphone's AI features smarter over time as well as increase daily performance and efficiency.

Track AI on the smartphone is portable, doesn’t require WI-FI and receives data in real-time to speed diagnoses. The unprecedented capabilities of Huawei’s smartphone allow Track AI to be used across the world, from an ophthalmologist in a UK hospital to a village doctor in a remote area of Africa.

Early trials will soon lead to widespread adoption. Developing a system based on AI requires gathering data from thousands of children, and data is currently being collecting by the research centres from testing in five countries across 3 continents (China, Mexico, UAE, Spain and UK). Once a mass of data has been aggregated, neural networks will be trained and a prototype device will be piloted later this year with plans to roll-out in 2020, helping healthcare workers diagnose and treat eye conditions early.

The new HUAWEI P30 an HUAWEI P30 Pro are immediately available globally with pricing information as follows:

HUAWEI P30 Pro

  • 8GB RAM + 128GB ROM - EUR 999
  • 8GB RAM + 256GB ROM - EUR 1,099
  • 8GB RAM + 512GB ROM - EUR 1,249

HUAWEI P30

  • 6GB RAM + 128GB ROM - EUR 799

-ends-

Contact information

H+K Strategies
Kandance Williamson
HuaweiP30@hkstrategies.com
Tel: +44 (0) 207 413 3000

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Gilead Sciences to Release Second Quarter 2019 Financial Results on Tuesday, July 30, 201916.7.2019 20:05:00 CESTPress release

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2019 financial results will be released on Tuesday, July 30, after the market closes. At 4:30 p.m. Eastern Time, Gilead’s management will host a conference call to discuss the company’s financial results for the second quarter 2019 and provide a business update. The live webcast of the call can be accessed at the company’s Investors page at http://investors.gilead.com/. Please connect to the company’s website at least 15 minutes prior to the start of the call to ensure adequate time for any software download that may be required to listen to the webcast. Alternatively, please call 877-359-9508 (U.S.) or 224-357-2393 (international) and dial the conference ID 8696029 to access the call. Telephone replay will be available approximately two hours after the call through 8:00 p.m. Eastern Time, August 1, 2019. To access the replay, please call 855-859-2056 (U.S.) or 404-537-3406 (international) and dial the confere

MSCI Schedules Investor Conference Call to Review Second Quarter 2019 Results16.7.2019 14:49:00 CESTPress release

MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, announced today it will release its results for second quarter 2019 on Thursday, August 1, 2019. MSCI's senior management will review the second quarter 2019 results on Thursday, August 1, 2019 at 11:00 AM Eastern Time. To listen to the live event, visit the events and presentations section of MSCI's Investor Relations homepage, http://ir.msci.com/events.cfm, or dial 1-877-376-9931 conference ID: 7743929 within the United States. International callers dial 1-720-405-2251 conference ID: 7743929. The earnings release and related investor presentation used during the conference call will be made available on MSCI's Investor Relations homepage. An audio recording of the conference call will be available on our Investor Relations website, http://ir.msci.com/events.cfm, beginning approximately two hours after the conclusion of the live event. Through August 4, 2019,

Keio Plaza Hotel Tokyo Offers “Tea Ceremony Experience and Luxurious Accommodations for Families” Package16.7.2019 14:05:00 CESTPress release

Keio Plaza Hotel Tokyo (KPH), one of Japan’s most prestigious international hotels located in Shinjuku, Tokyo, will begin offering a special summer accommodation package entitled “Tea Ceremony Experience and Luxurious Accommodations for Families” from July 20 to September 1, 2019. This accommodation package has been specially designed to keep families with children entertained by providing the unique cultural experience of a Japanese tea ceremony as fond memories of their summer vacation at our Hotel. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190716005325/en/ With the accommodation package, guests with children could experience unique cultural Japanese tea ceremony to learn how to make a green tea and its history. (Photo: Business Wire) The rooms offered in this accommodation package are the very popular “Two Queen Beds Rooms” located on the “Premier Grand” club floors with use of the Club Lounge included. The rooms are

Andersen Global Enters Senegal, Expands Presence in Africa16.7.2019 13:30:00 CESTPress release

Andersen Global is proud to announce a collaboration agreement with Cabex, one of the oldest legal and tax consulting firms in Senegal. Senegal thus becomes the thirteenth African country where Andersen Global has a member or collaborating firm offering legal services. Located in Dakar, Cabex has been offering services to local and foreign clients from the public and para-public sectors on matters relating to national and international issues for nearly thirty years. “Collaborating with Andersen Global shall expand our international scope and our transborder capabilities while giving us additional opportunities to expand into new markets,” Papa Alassane Ndir, Partner & General Manager at Cabex, said. “Henceforth, we are going to collaborate with many colleagues and experts from around the world and will be in a position to provide our clients more in-depth expertise.” Cherif Diaite, Partner & Technical Manager at Cabex, indicated that, “Owing to the challenge at an international level,

Mercatus Opens UK Office; Hires Chris Webb to Lead European Operations16.7.2019 13:00:00 CESTPress release

Mercatus, a leading asset and investment management platform for alternative investors and asset managers, today announced the opening of its European Headquarters in London, UK and the addition of Chris Webb as Senior Director leading the office in London. Chris was formerly a Global Director of Strategic Business Growth at FIS, with a deep focus on, and expertise in, alternative investments. “As Alternative fund managers and investors across Europe continue to embrace technology – and data – as a competitive weapon to drive future accelerated growth, we’re putting our resources in some of the largest markets. Our London office will be a critical hub for our workings in the UK, expanding upon our other offices in Silicon Valley, New York, Austin, Rome and Pune, India,” said Haresh Patel CEO of Mercatus. “We will continue to expand our local presence across Europe and Asia as our customers have deal and asset management teams in 118 countries with $540B AUM operating within the Mercatu

LivaNova Combats Leg Ischemia with Breakthrough Bidirectional Cannula16.7.2019 13:00:00 CESTPress release

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today launched its innovative arterial femoral cannula, Bi-Flow, designed to prevent limb ischemia during cardiac surgery. LivaNova Bi-Flow received CE Mark earlier this year and is the only bidirectional arterial cannula designed to prevent leg ischemia during cardiac surgery procedures requiring femoral artery cannulation. In a clinical study, Bi-Flow was easily inserted and removed without complications and was proven to provide simultaneous systemic and distal perfusion of the limb in a safe and reproducible way.1 Leg ischemia is caused by compromised blood flow to a lower limb and can affect up to 11% of patients undergoing complex cardiac surgery procedures.2 Consequences can include higher mortality, higher morbidity and longer hospital stays.3 The first procedure in Europe using a Bi-Flow cannula was performed by Patrick Perier M.D., FACS, at the Cardiovascular Center of Bad Neustadt, Germany. “I truly bel